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Abstract The quality of information that oncological patients receive from health care
professionals is an underestimated issue in Poland and Eastern European countries.
There is lack of sufficient data on this subject. The European Organization for Research
and Treatment of Cancer (EORTC) supplies a new tool for measuring the quality of
information provided to cancer patients. The purpose of the study is the translation into
Polish, pilot testing and preliminary validation of the EORTC information module
(INFO25). Following the EORTC translation procedures, forward and back translations
of the questionnaire were performed (English→Polish, Polish→English). The interme-
diate version of the INFO25 was pilot-tested together with the general questionnaire of
quality of life (EORTC QLQ-C30). Reliability, validity and known-group comparison
tests were performed. A total of 21 patients with different cancer diagnoses were
recruited into the study (7 women and 14 men; mean age of 60,2 years, age range 25–
73 years). Apart from filling out the INFO25, patients were interviewed about the
difficulties with answering every questionnaire item. Patients' comments were analyzed
and minor language changes were made to the initial translation. The internal consis-
tency of the INFO25 showed a reliability of 0,78. The final version of the Polish
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translation of the INFO25 module was obtained and approved by the EORTCQuality of
Life Department. It can now be used in clinical setting and for scientific purposes.
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Introduction
Information Received by Cancer Patients
The quality and quantity of information received by patients is an increasingly important
issue in oncology (Arraras et al. 2010; Rehnberg et al. 2001; Singer et al. 2013). We still
lack data concerning this matter, especially in Central and Eastern Europe. Medical staff
receives training in breaking bad news procedures (Kotlinowska and Wilusz 2010).
However, the type, quantity and quality of information the patients receive during the
diagnostic process and treatment is rarely investigated (Butow et al. 1997). There are
numerous benefits that may be related to providing adequate information, among them:
improvement of patient satisfaction, compliance and relations with medical staff as most
complaints received by health care professionals are caused by lack of proper commu-
nication. Additionally, proper transmission of information may diminish the distress
accompanying cancer treatment and improve cooperation with the patient and their
family (Butow et al. 1996; Degner et al. 1998; Kotlinowska andWilusz 2010; Mesters et
al. 2001). It remains unclear if patient satisfaction is linked to the amount of information
received, although there are data supporting this thesis (Butow et al. 1997). If the
physicians were to receive feedback on the topic of provided information, it could also
facilitate communication. Polish doctors seem to shy away from informing the patients
of the diagnosis and treatment options, finding it easier to talk to the family, which often
leaves them with a feeling of guilt and helplessness. This attitude has been recently
changing, also in other European countries, especially among younger professionals,
although communication skills are not included in postgraduate medical training
(Arraras et al. 2011; Bracci et al. 2008; Degner et al. 1998; Kotlinowska and Wilusz
2010). There is a need to adapt shared information depending on the recipient
(eg. his/her age). Senior patients in Poland are accustomed to receiving a very limited
amount of information regarding their health status. It is not knownwhether, and to what
extent, the population of these patients would benefit from a significant change of this
situation. At the same time, it seems that younger patients do not agree with such
paternalism in medicine and probably more commonly would like to be involved in the
decision making processes.
This topic requires further exploration as many cancer patients are still not satisfied
with the information provided (Montomery et al. 1999; Passalacqua et al. 2009;
Repetto et al. 2009). What is more it stays unclear if factors such as patient’s gender
or education status should influence the way of patient-doctor communication.
EORTC Information Module
The INFO25 information module is meant for use among cancer patients in different
disease sites and stages, in any moment of the treatment and in follow-up periods, as
526 M. Püsküllüoğlu et al.
well as for research or daily clinical purposes. The module can be presented on its
own or together with other EORTC questionnaires, for assessing the quality of life
dimensions (Arraras et al. 2010; Singer et al. 2013).
The INFO25 module is not the first one created to measure the information provided
to patients with cancer. However, the existing ones are focused mainly on patients’
satisfaction or needs (Arraras et al. 2011; Bonevski et al. 2000; Degner et al. 1998;
Mesters et al. 2001; Thomas et al. 2004).
As EORTC recommends linguistic and cultural adaptation to be performed in
every country the questionnaire would be used, we attempted formulating a correctly
translated and culturally adequate INFO25 questionnaire in Polish. We plan to
perform further studies with psychometric validation as it was done previously with
the EORTC QLQ-OG25 and the QLQ-OPT30 modules
(Chmielowska et al. 2013; Tomaszewski et al. 2013).
Patients and Methods
Patients
The patients were recruited prospectively between October and November 2012 at the
Department of Clinical Oncology of the University Hospital in Krakow, Poland. Patients
were eligible if they had a histologically confirmed diagnosis of a malignant tumour.
Study exclusion criteria were lack of consent to participate in the study and being unable
to fill out or understand the questionnaire. There were no restrictions as to the gender, age
or type of malignancy.
The research protocol was approved by the Jagiellonian University Ethics Committee
(registry KBET/253/B/2011). The study was performed in accordance with the ethical
standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Interview procedure
The patients were approached during their stay at the inpatient clinic and informed about
the study. After informed consent, they were interviewed by trained staff members. Each
patient completed the Polish version of the EORTCQLQ-C30, the INFO25module and a
personal questionnaire. The total time for completion of questionnaires and interviewwas
approximately 25 min. Information about every participant’s clinical history and physical
examinations was taken from patient records.
Questionnaire
The INFO25 is a 25-itemmodule comprised of four multi-item scales: information about
the disease (4 questions), information about medical tests (3 questions), information
about treatment (6 questions) and information about other services (4 questions). In
addition to the four multi-item scales, the EORTC INFO25 has 8 single items regarding
different places of receiving care, self-help attempts, receiving written and digital infor-
mation, satisfaction with the information received, wish to receive more information,
wish to receive less information, and helpfulness of the information obtained.
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A global score can be computed by averaging the scores from the 12 scales. Higher
scores indicate higher levels of information. Twenty-one out of twenty-five INFO25
questions are scored on a 1 to 4 point Likert scale (“not at all”, “a little”, “quite a bit”,
“very much”). Four questions (50, 51, 53, 54) are answered by either “yes” or “no”.
Questions 53 and 54 have an extra sub-question for patients who have replied “yes”,
in which they are invited to specify the topics in which they would like to have
received more or less information. Detailed information on how to score the EORTC
INFO25 questionnaire can be found in the EORTC QLQ-C30 scoring manual and its
later addendum (Fayers et al. 2001).
Translation procedure
The translation process of the EORTC INFO25 Polish version was authorized by the
EORTC Quality of Life Department. The translation was completed in accordance
with the EORTC translation procedure (Dewolf et al. 2009). The EORTC QLQ item
bank was searched for existing translated items but no such items were found.
First, two independent forward translations were made (English→Polish) by two
medical professionals, Polish native speakers (both holders of the Cambridge
Certificate of Proficiency in English). From the two translations a unified, prelimi-
nary Polish version of the INFO25 questionnaire was created, aided by discussion
between the translators and the project manager. This version was then translated
back into English by two independent English native speakers, both professional
translators fluent in Polish. The two obtained back translations were compared with
the original English version of the INFO25 questionnaire. This was done by the
project manager. Since no significant differences were noted between the original
version and the two back translations, all the translation process documentation was
sent to EORTC for approval, before beginning the pilot testing phase. Based on the
documentation, EORTC approved the preliminary Polish version of the INFO25
and sent back the intermediate Polish version of the INFO25, ready for pilot
testing.
Pilot testing
The intermediate version of the INFO25 was pilot-tested in 21 Polish cancer patients
(14 men and 7 women). Patients were asked whether they had any difficulty answer-
ing the questions, whether they found any of the questions confusing, upsetting or
containing difficult vocabulary. When a patient reported having trouble answering
any of the questions, they were asked to suggest an alternative way to formulate it.
None of the question was found problematic, confusing or offensive. However, in
case of question 46: ‘During your current disease or treatment, how much information
have you received on: Aspects of managing your illness at home?’ a single respon-
dent suggested inserting additional information. It has to be noted that the question
was said to be understood even without these supportive information. In case of
question 34: ‘During your current disease or treatment, how much information have
you received on: Whether the disease is under control?’ one patient reported that it
needs to be made more specific, but did not elaborate in what way. One respondent
advised replacing the words ‘written information’ by the word ‘brochure’ in question
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50. Another patient suggested that some may think that questions ‘Do you wish to
receive more information? If yes, please specify on which topics?’ (question 53b) and
‘Do you wish that you had received less information? If yes, please specify on which
topics?’ (question 54b) ask about the same thing. What is important, when asked to
suggest an alternative way to phrase the questions all patients decided to leave the
primary version of the questions.
Patients’ comments were analyzed and minor language changes were made to the
initial translation.
After this phase the final translation of the Polish version of the EORTC INFO25
questionnaire was obtained and approved by the EORTC Quality of Life Department.
Statistical analysis
Statistical analysis was conducted using computer software Statistica 10.0 PL by
StatSoft Poland. Scores for multi-item scales and for single items were calculated by
linear transformation of raw scores into a 0–100 score (Fayers et al. 2001). To analyze
the data, descriptive statistics (mean, standard deviation, percentage distribution)
were used.
Convergent validity was assessed by correlating each item with its own scale.
Discriminant validity was assessed by correlating each item with any other scale.
Evidence of item-convergent validity was defined as a correlation of 0,40 or greater
between an item and its own scale (corrected for overlap) (Arraras et al. 2010). A
scaling success for an item was seen when the correlation between an item and its
own scale was significantly higher than its correlation with other scales (Arraras et al.
2010; Fayers and Machin 2007). Cronbach alpha coefficient was calculated to assess
the internal consistency of the Polish version of the EORTC INFO25 questionnaire.
Internal consistency estimates of a magnitude of >0,70 were considered acceptable
(Fayers and Machin 2007).
Clinical validity was assessed using known-group comparisons. This assesses if the
questionnaires could be used to discriminate between subgroups of patients differing
in clinical status. The known groups used in this study were age (>60 or ≤60), gender
and current treatment (potentially curative vs. palliative) (Caruso et al. 2000;
Friedemann-Sanchez et al. 2007). Differences between groups were tested with the
Mann–Whitney test. The significance level was set at p≤0,05.
Results
A total of 21 patients were recruited into the study—7 women and 14 men. Patients’
clinical and demographic data are presented in [Table 1]. Nine patients had colorectal
cancer, four had gastric cancer, four suffered from head & neck malignancies, one had
breast cancer, one had gastric lymphoma, one had testicular cancer and one had an
astrocytoma.
Thirteen (62 %) patients said that they had received written information from their
physicians and seven (33 %) had reported obtaining such information on a CD.
Nineteen (90 %) patients wished they had received more information from their
doctors and only two (10 %) people wanted to receive less information.
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Reliability, convergent and discriminant validity of the Polish version of the
INFO25 are presented in [Table 2]. The internal consistency estimate of the full
questionnaire showed a reliability of 0,78.
Known-group comparison by age (>60 or ≤60), gender and current treatment
(potentially curative vs. palliative) is presented in [Table 3].
Table 1 Patients’ clinical and demographic data
Total (n=21) Women (n=7) Men (n=14)
Age (SD) 60,2 (10) 53,4 (13,5) 63,6 (5,8)
Education level
Elementary 4 (19 %) 2 2
High school 3 (14 %) 1 2
Vocational 8 (38 %) 2 6
University 6 (29 %) 2 4
Working status
Employed 16 (76 %) 6 10
Unemployed 1 (5 %) 0 1
Retired/Pensioner 3 (14 %) 0 3
Student 1 (5 %) 1 0
Treatment option (more than one treatment option possible)
Chemotherapy 13 (62 %) 3 10
Radiotherapy 1 (5 %) 1 0
Chemoradiotherapy 8 (38 %) 4 4
Hormonal therapy 1 (5 %) 1 0
Underwent previous surgical treatment 17 (81 %) 5 12
Current treatment
Curative 13 (62 %) 4 9
Palliative 8 (38 %) 3 5
Zubrod scale (SD) 0,67 (0,73) 1,14 (0,90) 0,43 (0,51)
SD – standard deviation
Table 2 EORTC INFO25: reliability, convergent and discriminant validity of multi-item scales
Item correlation within
scale*
Item correlation with
other scales*
Cronbach
alpha
Information about the disease 0,62–0,78 −0,12–0,87 0,71
Information about medical tests 0,45–0,74 −0,35–0,67 0,68
Information about treatment 0,43–0,56 −0,35–0,70 0,62
Information about other services 0,64–0,95 −0,56–0,51 0,73
Single items not included in this table
* Spearman correlation coefficients
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When the INFO25 Global Score was calculated by gender it showed that when
comparing information obtained by men (49,7±15,6) to information obtained by
women (55,7±11,5) there were no statistically significant differences (p=0,31).
When the INFO25 Global Score was calculated by current treatment it showed that
when comparing information obtained by patients from the potentially curative group
(48,3±15,4) to information obtained by patients from the palliative treatment group
(57,2±11,1) there were no statistically significant differences (p=0,29).
Discussion
The original version of the INFO25 module has been checked for validity and
reliability in multicenter studies (Arraras et al. 2010; Singer et al. 2013). This
manuscript presents results from the translation, pilot testing and preliminary
psychometric validation of the INFO25 information module. The module has
been also translated and tested in Spain (Arraras et al. 2011); however, to the
best of our knowledge, our study has been the first to perform a preliminary
validation and linguistic adaptation of the INFO25 questionnaire in Central and
Eastern Europe.
There are data suggesting the existence of relationship between the quality of
information received and the quality of life. In fact, some reports speculate that what
is most relevant is not the amount of information provided, but the influence it has on
the patient’s quality of life (Annunziata et al. 1998; Mallinger et al. 2005). Currently,
HRQoL in cancer patients has become an important outcome measurement also in
clinical trials (Blazeby et al. 2006). Therefore, any factors possibly influencing
HRQoL need valid measuring instruments. It has been shown that the cultural aspect
influences the relationship between the overall HRQoL and its components score
(Scott et al. 2008). Probably, the same statement is valid for quality of information
assessment.
Cross-cultural and proper linguistic adaptation was essential because we did not
want our results to be misleading. It has been shown that omitting parts of the
adaptation processes may result in future studies bias. Incorrectly or carelessly
translated and adapted questionnaires would not measure what they intend to assess
(De La Rosa et al. 2007). We managed to create a user-friendly Polish version of the
information module. The patients were willing to answer all questions, not finding
them awkward or inappropriate. It may seem surprising that also the question
considering sexual activity (question 43) was accepted and answered by all patients
as, unfortunately, in Poland it is still beyond everyday clinic practice to offer
support in the field of sexology. To the contrary, most of the patients wished to
receive more information not only on the causes of their disease or on further
treatment, but also on the impact the disease and its treatment might have on their
sexual activity.
Cultural barriers and difficulties, occasionally found during pilot studies of the
EORTC modules in other countries, have been suggested for example in elderly
patients’ population (Wadasadawala et al. 2008). Also in post-communist countries
of Central and Eastern Europe cultural adaptation is essential. These countries have
experienced significant changes in the last four decades. This also relates to the
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field of health care system that, in most ex-Eastern Bloc countries, stays badly
organized with limited access to psychological and social care for patients, as well
as poorly funded and underestimated position of family medicine (Oleszczyk et al.
2012).
In our study, the majority of patients wished they had received more information.
There are some reports claiming the important role of providing the patient with full
information or proving that there is a connection between patients’ satisfaction and
the amount of information provided. However, these reports do not focus on the type
of information given to the patients, and the data they present seem vague, which
means they require further testing and, in fact, they will be a topic of our ongoing
studies (Butow et al. 1997; Fujimori and Uchitomi 2009; Gysels and Higginson 2007;
Innes and Payne 2009).
The internal consistency of 0,78 suggests that all items can be added to generate a
score on perceived information provision. Two scales did not reach the required
Cronbach alpha value of >0.7. These were the Information about medical tests (0.68)
and Information about treatment (0.62). We recognise that our values are very close to
the required Cronbach alpha, and also that these are only guidelines, rather than
simple cut off or threshold scores. The other scales proved to have appropriate
Cronbach alpha values.
INFO25 multi-item scales show good convergent validity. According to our
preliminary results, women are more satisfied with the information they receive,
finding it more helpful. The gender differences in information needs have already
been mentioned in several reports (Friedemann-Sanchez et al. 2007; Fujimori and
Uchitomi 2009). Also, the data considering validation of the original INFO25 version
showed that the satisfaction-with-the-received-information scale differentiated be-
tween genders in the known-group comparison test, while such differences were
not found in the overall-helpfulness-of-the-information scale (Arraras et al. 2010).
Insufficient discriminant validity may be related to the fact that the group was
small or, less likely, to the stress accompanying the breaking bad news procedure,
insufficient training of health care professionals, patients’ inability to discriminate
whether they are informed about the disease itself, the diagnostic and therapeutic
procedures or other medical activities they are involved in.
As for known-group comparison, our results are largely consistent with the
English version (Arraras et al. 2010). Because of the small number of participants
in this pilot study many statistically significant differences could not have been seen.
However some trends could be detected. Taking into account the current treatment
intention, one can see that the “Information about current treatment” scale is a
potentially good candidate for a discriminator between patient differing in treatment
option. The same goes for the “Satisfaction with the received information” item when
one considers patients age.
These results show that INFO25 is a promising tool in performing research on
information quality and quantity received by cancer patients.
Acknowledgements The authors would like to thank Ms Joanna Gołąb for editing the English version of
the article. We also thank the European Organization for Research and Treatment of Cancer Quality of Life
Department for support during the translation process of the INFO25 module.
This study has not been funded.
Pilot Testing and Preliminary Validation of INFO25 Questionnaire 533
Open Access This article is distributed under the terms of the Creative Commons Attribution License
which permits any use, distribution, and reproduction in any medium, provided the original author(s) and
the source are credited.
References
Annunziata, M. A., Foladore, S., Magri, M. D., Crivellari, D., Feltrin, A., Bidoli, E., & Veronesi, A. (1998).
Does the information level of cancer patients correlate with quality of life? A prospective study.
Tumori, 84(6), 619–623.
Arraras, J. I., Greimel, E., Sezer, O., Chie, W. C., Bergenmar, M., Costantini, A., et al. (2010). An
international validation study of the EORTC QLQ-INFO25 questionnaire: An instrument to assess
the information given to cancer patients. European Journal of Cancer, 46(15), 2726–2738.
Arraras, J. I., Manterola, A., Hernández, B., Arias de la Vega, F., Martínez, M., Vila, M., et al. (2011). The
EORTC information questionnaire, EORTC QLQ-INFO25. Validation study for Spanish patients.
Clinical & Translational Oncology, 13(6), 401–410.
Blazeby, J. M., Avery, K., Sprangers, M., Pikhart, H., Fayers, P., & Donovan, J. (2006). Health-related
quality of life measurement in randomized clinical trials in surgical oncology. Journal of Clinical
Oncology, 24(19), 3178–3186.
Bonevski, B., Sanson-Fisher, R., Girgis, A., Burton, L., Cook, P., &Boyes, A. (2000). Evaluation of an instrument
to assess the needs of patients with cancer. Supportive care review group. Cancer, 88(1), 217–225.
Bracci, R., Zanon, E., Cellerino, R., Gesuita, R., Puglisi, F., Aprile, G., et al. (2008). Information to cancer
patients: A questionnaire survey in three different geographical areas in Italy. Supportive Care in
Cancer, 16(8), 869–877.
Butow, P. N., Kazemi, J. N., Beeney, L. J., Griffin, A. M., Dunn, S. M., & Tattersall, M. H. (1996). When the
diagnosis is cancer: Patient communication experiences and preferences. Cancer, 77(12), 2630–2637.
Butow, P. N., Maclean, M., Dunn, S. M., Tattersall, M. H., & Boyer, M. J. (1997). The dynamics of change:
Cancer patient’s preferences for information involvement and support. Annals of Oncology, 8(9), 857–
863.
Caruso, A., Di Francesco, B., Pugliese, P., Cinanni, V., & Corlito, A. (2000). Information and awareness of
diagnosis and progression of cancer in adult and elderly cancer patients. Tumori, 86(3), 199–203.
Chmielowska, K., Tomaszewski, K. A., Pogrzebielski, A., Brandberg, Y., & Romanowska-Dixon, B.
(2013). Translation and validation of the polish version of the EORTC QLQ-OPT30 module for the
assessment of health-related quality of life in patients with uveal melanoma. European Journal of
Cancer Care, 22(1), 88–96.
De La Rosa, M., Rahill, G. J., Rojas, P., & Pinto, E. (2007). Cultural adaptations in data collection: Field
experiences. Journal of Ethnicity in Substance Abuse, 6(2), 163–180.
Degner, L. F., Davison, B. J., Sloan, J. A., & Mueller, B. (1998). Development of a scale to measure
information needs in cancer care. Journal of Nursing Measurement, 6(2), 137–153.
Dewolf, L., Koller, M., Velikova, G., Johnson, C., Neil Scott, N., Bottomley, A., et al. (2009). EORTC
quality of life group translation procedure. Brussels: European Organisation for Research and Treat-
ment of Cancer.
Fayers, P., Aaronson, N. K., Bjordal, K., Grønvold, M., Curran, D., & Bottomley, A. (2001). The EORTC
QLQ-C30 scoring manual. Brussels: European organisation for research and treatment of cancer.
Fayers, P., & Machin, D. (2007). Quality of life: The assessment analysis and interpretation of patient
reported outcomes. Chichester: John Wiley & Sons.
Friedemann-Sanchez, G., Griffin, J. M., & Partin, M. R. (2007). Gender differences in colorectal cancer
screening barriers and information needs. Health Expectations, 10(2), 148–160.
Fujimori, M., & Uchitomi, Y. (2009). Preferences of cancer patients regarding communication of bad news:
A systematic literature review. Japanese Journal of Clinical Oncology, 39(4), 201–216.
Gysels, M., & Higginson, I. J. (2007). Interactive technologies and videotapes for patient education in
cancer care: Systematic review and meta-analysis of randomized trials. Supportive Care in Cancer,
15(1), 7–20.
Innes, S., & Payne, S. (2009). Advanced cancer patients’ prognostic information preferences: A review.
Palliative Medicine, 23(1), 29–39.
Kotlinowska, B., & Wilusz, M. (2010). Breaking bad news—information for doctors. Przegla d Lekarski,
67(3), 228–230.
534 M. Püsküllüoğlu et al.
Mallinger, J. B., Griggs, J. J., & Shields, C. G. (2005). Patient-centered care and breast cancer survivors’
satisfaction with information? Patient Education and Counseling, 57(3), 342–349.
Mesters, I., Van den Borne, B., De Boer, M., & Pruyn, J. (2001). Measuring information needs among
cancer patients. Patient Education and Counseling, 43(3), 253–262.
Montomery, C., Lydon, A., & Lloyd, K. (1999). Psychological distress among cancer patients and informed
consent. Journal of Psychosomatic Research, 46(3), 241–245.
Oleszczyk, M., Svab, I., Seifert, B., Krztoń-Królewiecka, A., & Windak, A. (2012). Family medicine in
post-communist Europe needs a boost. Exploring the position of family medicine in healthcare systems
of Central and Eastern Europe and Russia. BMC Family Practice, 13, 15.
Passalacqua, R., Caminiti, C., Campione, F., Diodati, F., Todeschini, R., Bisagni, G., et al. (2009).
Prospective, multicenter, randomized trial of a new organizational modality for providing information
and support to cancer patients. Journal of Clinical Oncology, 27(11), 1794–1799.
Rehnberg, G., Absetz, P., & Aro, A. R. (2001). Women’s satisfaction with information at breast biopsy in
breast cancer screening. Patient Education and Counseling, 42(1), 1–8.
Repetto, L., Piselli, P., Raffaele, M., Locatelli, C., Italiano, G., & di Oncologia Geriatrica (GIOGer). (2009).
Communicating cancer diagnosis and prognosis: When the target is the elderly patient – a GIOGer
study. European Journal of Cancer, 45(3), 374–383.
Scott, N. W., Fayers, P. M., Aaronson, N. K., Bottomley, A., de Graeff, A., Groenvold, M., et al. (2008).
The relationship between overall quality of life and its subdimensions was influenced by culture:
analysis of an international database. Journal of Clinical Epidemiology, 61(8), 788–795.
Singer, S., Engelberg, P. M., Weißflog, G., Kuhnt, S., & Ernst, J. (2013). Construct validity of the EORTC
quality of life questionnaire information module. Quality of Life Research, 22(1), 123–129.
Thomas, R., Kaminski, E., Stanton, E., & Williams, M. (2004). Measuring information strategies in
oncology: Developing an information satisfaction questionnaire. European Journal of Cancer Care,
13(1), 65–70.
Tomaszewski, K. A., Püsküllüoğlu, M., Biesiada, K., Bochenek, J., Nieckula, J., & Krzemieniecki, K.
(2013). Validation of the Polish version of the EORTC QLQ-C30 and the QLQ-OG25 for the
assessment of health-related quality of life in patients with oesophago-gastric cancer. Journal of
Psychosocial Oncology, 31(2), 191–203.
Wadasadawala, T., Murthy, V., Mahantshetty, U., Engineer, R., Shrivastava, S., & Dinshaw, K. (2008). The
European organization for research and treatment of cancer prostate-specific quality of life module
(PR-25) in Hindi and Marathi: Translation and pilot testing process. Journal of Cancer Research and
Therapeutics, 4(2), 64–69.
Pilot Testing and Preliminary Validation of INFO25 Questionnaire 535
